Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
European Urology Focus|August 25, 2021
Novel Volumetric and Morphological Parameters Derived from Three-dimensional Virtual Modeling to Improve Comprehension of Tumor's Anatomy in Patients with Renal CancerLorenzo Bianchi, Riccardo Schiavina, Barbara Bortolani, et al.
Urologic Oncology|January 31, 2022
Assessing pentafecta achievement after robot-assisted radical cystectomy and its association with surgical experience: Results from a high-volume institutionPietro Piazza, Carlo Andrea Bravi, Stefano Puliatti, et al.
Minerva Urology and Nephrology|June 18, 2025
Sexual function outcomes in men undergoing minimal invasive ablative techniques for prostate cancer: a ESRU/YAU urotech systematic review and pooled analysisFederico Piramide, Alessandro Veccia, Lazaros Tzelves, et al.
BJU International|December 26, 2025
Is there still a role for ureteric frozen section analysis during radical cystectomy?Attilio Barretta, Pietro Piazza, Calogero Catanzaro, et al.
BJU International|January 13, 2026
Impact of cumulative smoking exposure on morbidity after robot-assisted radical cystectomyPietro Piazza, Attilio Barretta, Carlo Andrea Bravi, et al.
Minerva Urology and Nephrology|December 1, 2020
Percutaneous tumor ablation versus partial nephrectomy for small renal mass: the impact of histologic variant and tumor sizeLorenzo Bianchi, Federico Mineo Bianchi, Francesco Chessa, et al.
European Urology|March 3, 2021
The Impact of Previous Prostate Surgery on Surgical Outcomes for Patients Treated with Robot-assisted Radical Cystectomy for Bladder CancerGiuseppe Rosiello, Pietro Piazza, Victor Tames, et al.
Minerva Urology and Nephrology|October 26, 2022
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaborationCarlo A Bravi, Elio Mazzone, Paolo Dell'oglio, et al.
Cancers|April 13, 2023
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage TreatmentLorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, et al.
Cancers|January 8, 2023
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or RecurrenceLorenzo Bianchi, Francesco Ceci, Francesco Costa, et al.
Pageof 9